Becton Dickinson and Company

BDX.US
Healthcare · Medical Instruments & Supplies
166.34
+7.42 (+4.67%)
USD · NYSE

Company Information

Company Name
Becton Dickinson and Company
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
ISIN: US0758871091
CIK: 0000010795
CUSIP: 075887109
Currency: USD
Full Time Employees: 60,000
Phone: 201 847 6800
Fiscal Year End: September
IPO Date: Jan 01, 1987
Description:

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care

Address:

1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880

People

Directors & Officers

Name Title Year Born
Mr. Thomas E. Polen Jr. President, CEO & Chairman 1973
Mr. Michael C. Feld Executive VP & Chief Revenue Officer 1981
Mr. Vitor Roque Executive VP & CFO 1983
Ms. Elizabeth McCombs Executive VP & CTO 1977
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. Senior VP & Chief Scientific Officer NA
Ms. Denise Russell Fleming Executive Vice President & Chief Information Officer 1971

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 23, 2026 Ro Khanna N/A Purchase N/A $156.01 N/A
Mar 17, 2026 Kevin Hern N/A Sale N/A $161.64 N/A
Feb 26, 2026 Michael Feld N/A Sale 75.00 $181.84 $13.64K
Feb 18, 2026 Bertram L Scott N/A Sale 953.00 $182.61 $174.03K
Jan 29, 2026 Ro Khanna N/A Purchase N/A $201.27 N/A
Jan 26, 2026 Michael Feld N/A Sale 75.00 $202.73 $15.20K
Jan 23, 2026 Ro Khanna N/A Purchase N/A $201.84 N/A
Jan 15, 2026 Michael David Garrison N/A Sale 1.61K $207.46 $334.01K
Dec 26, 2025 Michael Feld N/A Sale 74.00 $196.08 $14.51K
Dec 17, 2025 Michael David Garrison N/A Sale 629.00 $196.03 $123.30K
Dec 01, 2025 Michael Feld N/A Sale 75.00 $193.36 $14.50K
Nov 10, 2025 Ro Khanna N/A Sale N/A $181.62 N/A
Nov 07, 2025 Bertram L Scott N/A Sale 217.00 $176.58 $38.32K
Nov 03, 2025 Ro Khanna N/A Sale N/A $177.20 N/A
Oct 27, 2025 Michael Feld N/A Sale 57.00 $186.01 $10.60K
Sep 29, 2025 Ro Khanna N/A Purchase N/A $183.85 N/A
Sep 26, 2025 Michael Feld N/A Sale 58.00 $181.03 $10.50K
Sep 10, 2025 Claire Fraser N/A Sale 917.00 $187.50 $171.94K
Aug 08, 2025 Claire Fraser N/A Sale 863.00 $192.30 $165.95K
Aug 04, 2025 Ro Khanna N/A Purchase N/A $178.99 N/A

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 36.68M Dec 31, 2025 13.31% $0.10 13.01%
BlackRock Inc 26.15M Mar 31, 2026 9.49% $0.07 -5.41%
Vanguard Capital Management, LLC 18.49M Mar 31, 2026 6.71% $0.07 0.00%
Vanguard Portfolio Management, LLC 15.32M Mar 31, 2026 5.56% $0.13 0.00%
State Street Corp 13.82M Mar 31, 2026 5.02% $0.08 -1.19%
Arnhold & S. Bleichroeder Advisers, LLC 11.93M Mar 31, 2026 4.33% $3.18 2.42%
Amvescap Plc. 10.17M Mar 31, 2026 3.69% $0.16 168.42%
T. Rowe Price Investment Management,Inc. 9.69M Mar 31, 2026 3.52% $1.05 -60.64%
Massachusetts Financial Services Company 9.10M Mar 31, 2026 3.30% $0.75 -4.06%
Geode Capital Management, LLC 7.11M Mar 31, 2026 2.58% $0.07 3.22%
Wellington Management Company LLP 6.62M Mar 31, 2026 2.40% $0.19 24.84%
Franklin Resources Inc 5.36M Mar 31, 2026 1.95% $0.21 2.26%
T. Rowe Price Associates, Inc. 4.42M Mar 31, 2026 1.60% $0.08 3.27%
ClearBridge Advisors, LLC 4.14M Mar 31, 2026 1.50% $0.57 1.17%
Morgan Stanley - Brokerage Accounts 4.02M Mar 31, 2026 1.46% $0.04 19.14%
NORGES BANK 3.78M Dec 31, 2025 1.37% $0.08 -0.25%
JPMorgan Chase & Co 3.57M Mar 31, 2026 1.30% $0.04 0.00%
American Century Companies Inc 3.41M Mar 31, 2026 1.24% $0.28 8.83%
Charles Schwab Investment Management Inc 3.32M Mar 31, 2026 1.21% $0.08 3.90%
Bank of America Corp 2.67M Mar 31, 2026 0.97% $0.03 -5.15%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 First Eagle Global A 9.15M 3.32% ▲ 13.57% Jun 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 8.75M 3.18% ▼ 3.45% Jun 30, 2026
3 Vanguard 500 Index Investor 7.15M 2.60% ▼ 4.04% Jun 30, 2026
4 Vanguard Mid Cap Index Institutional 5.97M 2.17% ▼ 3.34% Jun 30, 2026
5 iShares Core S&P 500 ETF 3.80M 1.38% ▲ 0.32% Jun 30, 2026
6 Fidelity 500 Index 3.64M 1.32% ▼ 0.14% May 31, 2026
7 State Street® SPDR® S&P 500® ETF 3.33M 1.21% ▼ 1.29% Jun 30, 2026
8 Putnam Large Cap Value A 3.04M 1.10% ▲ 0.00% Jun 30, 2026
9 Vanguard Equity-Income Inv 2.97M 1.08% ▲ 36.02% Mar 31, 2026
10 Vanguard Value Index Inv 2.62M 0.95% ▼ 1.43% Jun 30, 2026

Financial Highlights

Market Cap: $43.79B
EBITDA: $6.16B
P/E Ratio: $27.78
PEG Ratio: $1.11
Book Value: $87.58
Dividend/Share: $4.18
Dividend Yield: 2.67%
Earnings/Share: $5.72
Profit Margin: 5.12%
Operating Margin: 14.74%
ROA (TTM): 4.38%
ROE (TTM): 6.67%
Revenue (TTM): $22.23B
Revenue/Share (TTM): $77.99
Earnings Growth (YOY): 28.60%
Revenue Growth (YOY): 5.20%

Valuation Metrics

Enterprise Value: $59.55B
Trailing P/E: 27.78
Forward P/E: 11.59

Shares Statistics

Shares Outstanding: 275.54M
Shares Float: 274.69M
% Insiders: 42.10%
% Institutions: 9,918.70%
Short % Float: 4.29%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$21.84B
Cost of Goods Sold
adjust
$-11.92B
Gross Profit
subtotal
$9.92B
SG&A
adjust
$-5.28B
R&D
adjust
$-1.26B
Other Operating Expense
adjust
$-805.00M
Operating Income
subtotal
$2.58B
Other / Non-Operating Items
adjust
$-900.00M
Net Income
subtotal
$1.68B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BDX.US!